These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 8953513)
1. Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier. Terao T; Hisanaga E; Sai Y; Tamai I; Tsuji A J Pharm Pharmacol; 1996 Oct; 48(10):1083-9. PubMed ID: 8953513 [TBL] [Abstract][Full Text] [Related]
2. Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein. Karlsson J; Kuo SM; Ziemniak J; Artursson P Br J Pharmacol; 1993 Nov; 110(3):1009-16. PubMed ID: 7905337 [TBL] [Abstract][Full Text] [Related]
3. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge. Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222 [TBL] [Abstract][Full Text] [Related]
4. Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Hunter J; Hirst BH; Simmons NL Pharm Res; 1993 May; 10(5):743-9. PubMed ID: 8100632 [TBL] [Abstract][Full Text] [Related]
5. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter. Wu X; Whitfield LR; Stewart BH Pharm Res; 2000 Feb; 17(2):209-15. PubMed ID: 10751037 [TBL] [Abstract][Full Text] [Related]
6. Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux system. Nakayama A; Saitoh H; Oda M; Takada M; Aungst BJ Eur J Pharm Sci; 2000 Oct; 11(4):317-24. PubMed ID: 11033075 [TBL] [Abstract][Full Text] [Related]
7. Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation. Fricker G; Drewe J; Huwyler J; Gutmann H; Beglinger C Br J Pharmacol; 1996 Aug; 118(7):1841-7. PubMed ID: 8842452 [TBL] [Abstract][Full Text] [Related]
8. Nonlinear intestinal absorption of 5-hydroxytryptamine receptor antagonist caused by absorptive and secretory transporters. Tamai I; Saheki A; Saitoh R; Sai Y; Yamada I; Tsuji A J Pharmacol Exp Ther; 1997 Oct; 283(1):108-15. PubMed ID: 9336314 [TBL] [Abstract][Full Text] [Related]
9. Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers. Wils P; Phung-Ba V; Warnery A; Lechardeur D; Raeissi S; Hidalgo IJ; Scherman D Biochem Pharmacol; 1994 Oct; 48(7):1528-30. PubMed ID: 7945455 [TBL] [Abstract][Full Text] [Related]
10. The involvement of P-glycoprotein in berberine absorption. Pan GY; Wang GJ; Liu XD; Fawcett JP; Xie YY Pharmacol Toxicol; 2002 Oct; 91(4):193-7. PubMed ID: 12530470 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells. Takanaga H; Ohnishi A; Matsuo H; Sawada Y Biol Pharm Bull; 1998 Oct; 21(10):1062-6. PubMed ID: 9821810 [TBL] [Abstract][Full Text] [Related]
12. What kinds of substrates show P-glycoprotein-dependent intestinal absorption? Comparison of verapamil with vinblastine. Ogihara T; Kamiya M; Ozawa M; Fujita T; Yamamoto A; Yamashita S; Ohnishi S; Isomura Y Drug Metab Pharmacokinet; 2006 Jun; 21(3):238-44. PubMed ID: 16858128 [TBL] [Abstract][Full Text] [Related]
13. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting. Dahan A; Amidon GL Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926 [TBL] [Abstract][Full Text] [Related]
14. Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol. Kato Y; Miyazaki T; Kano T; Sugiura T; Kubo Y; Tsuji A J Pharm Sci; 2009 Jul; 98(7):2529-39. PubMed ID: 19067419 [TBL] [Abstract][Full Text] [Related]
15. Contribution of P-glycoprotein to bunitrolol efflux across blood-brain barrier. Matsuzaki J; Yamamoto C; Miyama T; Takanaga H; Matsuo H; Ishizuka H; Kawahara Y; Kuwano M; Naito M; Tsuruo T; Sawada Y Biopharm Drug Dispos; 1999 Mar; 20(2):85-90. PubMed ID: 10206323 [TBL] [Abstract][Full Text] [Related]
16. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs. Dahan A; Amidon GL Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230 [TBL] [Abstract][Full Text] [Related]
17. Concentration-dependent effect of naringin on intestinal absorption of beta(1)-adrenoceptor antagonist talinolol mediated by p-glycoprotein and organic anion transporting polypeptide (Oatp). Shirasaka Y; Li Y; Shibue Y; Kuraoka E; Spahn-Langguth H; Kato Y; Langguth P; Tamai I Pharm Res; 2009 Mar; 26(3):560-7. PubMed ID: 19002566 [TBL] [Abstract][Full Text] [Related]
18. Limited influence of P-glycoprotein on small-intestinal absorption of cilostazol, a high absorptive permeability drug. Toyobuku H; Tamai I; Ueno K; Tsuji A J Pharm Sci; 2003 Nov; 92(11):2249-59. PubMed ID: 14603510 [TBL] [Abstract][Full Text] [Related]
19. Pretreatment with potent P-glycoprotein ligands may increase intestinal secretion in rats. Hanafy A; Langguth P; Spahn-Langguth H Eur J Pharm Sci; 2001 Feb; 12(4):405-15. PubMed ID: 11231107 [TBL] [Abstract][Full Text] [Related]
20. Evidence for a non-MDR1 component in digoxin secretion by human intestinal Caco-2 epithelial layers. Lowes S; Cavet ME; Simmons NL Eur J Pharmacol; 2003 Jan; 458(1-2):49-56. PubMed ID: 12498906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]